Effect of chronic treatment with biosynthetic growth hormone (GH) on the GH response to double GH-releasing hormone administration in children with short stature

Journal of Endocrinological Investigation

Volumn 20, Issue 2, 1997, Pages 72-76

  Scacchi, M ^a   Danesi, L ^a   Pincelli, A I ^a   Dubini, A ^a   Cavagnini, F ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

GH treatment; GHRH; Short stature

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOCRINE FUNCTION; FEMALE; GROWTH HORMONE RELEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; MALE; NEGATIVE FEEDBACK; PHYSIOLOGY; PROVOCATION TEST; SCHOOL CHILD; SHORT STATURE;

EID: 0030899408     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347979     Document Type: Article

References (20)

1. Berelowitz M., Szabo L.A., Frohman L.A., Firestone S., Chu I., Hintz R.L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212: 1279, 1981.
2. Nakamoto J.M., Gertner J.M., Press C.M., Hintz R.L. Suppression of the growth hormone (GH) response to clonidine and GH-releasing hormone by exogenous GH. J. Clin. Endocrinol. Metab. 62: 822, 1986.
3. Pontiroli A.E., Lanzi R., Pozza G. Inhibition of the growth hormone (GH) response to GH-releasing hormone by constant met-GH infusions. J. Clin. Endocrinol. Metab. 68: 956, 1989.
4. Sartorio A., Spada A., Morabito F., Faglia G. Different GH responsiveness to repeated GHRH administration in normal children and adults. J. Endocrinol. Invest. 11: 727, 1988.
5. Ghigo E., Gofli S., Mazza E., Arvat E., Procopio M., Bellone J., Müller E.E., Camanni F. Repeated GH-releasing hormone administration unravels different GH secretory patterns in normal adults and children. Acta Endocrinol. (Copenh.) 120: 598, 1989.
6. Tanaka T., Yano H., Umezawa S., Ohmae Y., Hashimoto N., Miki Y., Kagawa J., Tanae A.,Hibi I. Change in the growth hormone (GH) response to GH-releasing factor (GRF) caused by exogenous GH in short children. Endocrinol. Jpn. 37: 239, 1990.
7. Gil-Ad I., Klinger B., Pertzelan A., Erster B., Silbergeld A., Talpaz H., Laron Z. Growth hormone therapy in normal short children induces a transitory decrease in plasma growth hormone releasing hormone levels and in human growth hormone responsiveness to exogenous growth hormone releasing hormone. J. Endocrinol. Invest. 15: 735, 1992.
8. Sartorio A., Conti A., Morabito F., Faglia G. Effect of a long-term methionyl growth hormone treatment on growth hormone releasing hormone-induced growth hormone secretion in patients with constitutional growth delay. Eur. J. Pediatr. 151: 148, 1992.
9. Hanew K., Goh M., Sato S., Shimizu Y., Sasaki A., Aida M., Yoshinaga K. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency. J. Clin. Endocrinol. Metab. 66: 715, 1988.
10. Bilezikjian L.M., Vale W.W. Chronic exposure of cultured rat anterior pituitary cells to GRF causes partial loss of responsiveness to GRF. Endocrinology 115: 2032, 1984.
11. Ceda G.P., Hoffman A.R. Growth hormone-releasing factor desensitization in rat anterior pituitary cells in vitro. Endocrinology 116: 1334, 1985.
12. Massara F., Ghigo E., Molinatti P., Mazza E., Locatelli V., Müller E.E., Camanni F. Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man. Acta Endocrinol. (Copenh.) 113: 12, 1986.
13. Arosio M., Losa M., Bazzoni N., Bochicchio D., Palmieri E., Nava C., Faglia G. Effects of propranolol on GH responsiveness to repeated GH-releasing hormone stimulation in normal subjects. Acta Endocrinol. (Copenh.) 122: 1, 1990.
14. Ghigo E., Arvat E., Valente E., Nicolosi M., Boffano G.M., Procopio M., Bellone J., Maccario M., Mazza E., Camanni F. Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults. Neuroendocrinology 54: 291, 1991.
15. Lanzi R., Tannenbaum G.S. Time course and mechanism of growth hormone's negative feedback effect on its own spontaneous release. Endocrinology 130: 780, 1992.
16. Lanzi R, Tannenbaum G.S. Time-dependent reduction and potentiation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: role for somatostatin. Endocrinology 130: 1822, 1992.
17. Bertherat J., Timsit J., Bluet-Pajot M.T., Mercadier J.J., Gourdji D., Kordon C., Epelbaum J. Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat. J. Clin. Invest. 91: 1783, 1993.
18. Ross R.J.M., Borges F., Grossman A., Smith R., Ngahfoong L., Rees L.H., Savage M.O., Besser G.M. Growth hormone pretreatment in man blocks the response to growth hormone-releasing hormone: evidence for a direct effect of growth hormone. Clin. Endocrinol. (Oxf.) 26: 117, 1987.
19. Pontiroli A.E., Lanzi R., Monti L.D., Sandoli E., Pozza G. Growth hormone (GH) autofeedback on GH response to GH-releasing hormone. Role of free fatty acids and somatostatin. J. Clin. Endocrinol. Metab. 72: 492, 1991.
20. Glenn K.C. Regulation of release of somatotropin from in vitro cultures of bovine and porcine pituitary cells. Endocrinology 118: 2450, 1986.